
ORGO
NSCOrganogenesis Holdings Inc.
Healthcare•Drug Manufacturers - Specialty & Generic
Watchlists:
Last updated: Sunday 20th July 2025
4.37
+0.01 (0.23%)
Prev Close:4.36
Open:4.45
Bid:4.34
Ask:4.5
52 Week Range
2.286.71
Volume:1,308,816
Mkt Cap:511 M
60
MarketXLS Rank ®
Buy
Price Target
$5.03
+15.1%
Financial Statements
ORGO - Income Statement (Annual)
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Invalid date | |
---|---|---|---|---|---|---|---|---|---|---|
Accretion On Preferred Stock | 412000.0 | |||||||||
Accrued Preferred Stock Dividends | 937000.0 | -5 M | 645000.0 | |||||||
Acquisition Expense | 87 M | |||||||||
Depreciation And Amortization | 14 M | 10 M | 6 M | 6 M | 4 M | 3 M | -3 M | -4 M | ||
Gain On Sale Of PPE | -559000.0 | -1 M | 8000.0 | |||||||
General And Administrative Expense | 295 M | 270 M | 284 M | 250 M | 204 M | 200 M | -5 M | -4 M | ||
Gross Profit Margin (profit Margin After CGS) | 366 M | 327 M | 346 M | 353 M | 251 M | 185 M | 125 M | 137 M | 91 M | |
Interest Expense Non Operating | 197000.0 | 137000.0 | 2 M | 7 M | 11 M | 9 M | 11 M | 8 M | ||
Loss And Loss Adjustment Expected Incurred | 76 M | |||||||||
Minority Interests | -863000.0 | |||||||||
Misc Other Special Charges | 20000.0 | 57000.0 | -13000.0 | -2 M | 2 M | -2 M | -2 M | -9000.0 | ||
Net Income (loss) | 861000.0 | 5 M | 16 M | 94 M | 17 M | -40 M | -65 M | -8 M | -208698.0 | |
Net Income Common Stockholders | -937000.0 | 5 M | 16 M | 94 M | 17 M | -41 M | -65 M | -8 M | -208698.0 | |
Net Income Continuous Operations | 861000.0 | 5 M | 16 M | 94 M | 17 M | -40 M | -65 M | -8 M | -208698.0 | |
Net Income Discontinuous Operations | 1 M | 418000.0 | ||||||||
Net Non Operating Interest Income Expense | -197000.0 | -137000.0 | 2 M | -7 M | -11 M | -9 M | -11 M | -9 M | ||
Non Recurring Operation Expense | -2 M | |||||||||
Normalized Income | 12 M | |||||||||
Operating Income | -1 M | 13 M | 22 M | 72 M | 27 M | -29 M | -52 M | -5 M | -208698.0 | |
Operating Income Before Depreciation (EBITDA) | 23 M | 34 M | 40 M | 87 M | 37 M | -22 M | -47 M | -783000.0 | -15 M | |
Operating Expense | 368 M | 314 M | 324 M | 281 M | 224 M | 214 M | -176 M | -143 M | -208698.0 | |
Other Gand A | 295 M | 270 M | 284 M | 250 M | 204 M | 200 M | -5 M | -4 M | ||
Other Impairment Of Capital Assets | 19 M | |||||||||
Other Operating Expenses | 20 M | -113000.0 | -206000.0 | -153000.0 | -111000.0 | 6 M | 3 M | -1 M | 208698.0 | |
Otherunder Preferred Stock Dividend | 1 M | -5 M | 645000.0 | |||||||
Preferred Stock Dividends | 1 M | -5 M | 645000.0 | |||||||
Provision For Gain Loss On Disposal | 1 M | 418000.0 | ||||||||
Rent And Landing Fees | -2 M | -2 M | ||||||||
Research Expense | 50 M | 44 M | 40 M | 145 M | 20 M | 15 M | 11 M | 9 M | ||
Restructring And Mn A Income | 4 M | 2 M | 5 M | -423000.0 | ||||||
Salaries And Wages | 76 M | |||||||||
Selling And Marketing Expense | 162 M | 134 M | ||||||||
Selling Expense | 162 M | 134 M | ||||||||
Total Income Available For Interest Expense (EBIT) | -3 M | 11 M | 22 M | 70 M | 29 M | -31 M | -54 M | -6 M | -15 M | |
Total Revenues | 482 M | 433 M | 451 M | 467 M | 338 M | 261 M | 193 M | 199 M | 139 M | |
Total Expenses | 483 M | 421 M | 429 M | 395 M | 312 M | 290 M | -245 M | -204 M | -48 M | |
Total Revenue | 482 M | 433 M | 451 M | 467 M | 338 M | 261 M | 193 M | 199 M | 139 M | |
Write Down | 87 M | |||||||||
Amord | 30 M | 29 M | 29 M | 30 M | 29 M | 26 M | -4 M | -2 M | ||
Avgshs | 132 M | 131 M | 130 M | 128 M | 108 M | 93 M | 69 M | 64 M | 8 M | |
Avgshsdt | 132 M | 133 M | 132 M | 134 M | 111 M | 69 M | 64 M | 7 M | ||
Basiceps | -0.01 | 0.04 | 0.12 | 0.74 | 0.17 | -0.44 | -0.07 | |||
Basicepscont | -0.01 | 0.04 | 0.12 | 0.74 | 0.17 | -0.44 | ||||
Cor | 116 M | 106 M | 105 M | 114 M | 87 M | 76 M | -69 M | -61 M | -48 M | |
Depamor | 14 M | 10 M | 6 M | 6 M | 4 M | 3 M | -3 M | -4 M | ||
Dileps | -0.01 | 0.04 | 0.12 | 0.71 | 0.16 | -0.44 | -0.94 | -0.14 | -0.03 | |
Dilepscont | -0.01 | 0.04 | 0.12 | 0.71 | 0.16 | |||||
Intinc | 78000.0 | -469000.0 | -908000.0 | |||||||
Netincdisc | 861000.0 | 5 M | 16 M | 94 M | 17 M | -40 M | -65 M | -8 M | -208698.0 | |
Othincexp | 19 M | -57000.0 | -13000.0 | 2 M | -2 M | 2 M | 2 M | 9000.0 | ||
Pretaxinc | -3 M | 10 M | 20 M | 63 M | 18 M | -40 M | -65 M | -15 M | -15 M | |
Resdev | 50 M | 44 M | 40 M | 145 M | 20 M | 15 M | 11 M | 9 M | ||
Restruct | 4 M | 2 M | 5 M | -423000.0 | ||||||
Sga | 295 M | 270 M | 284 M | 250 M | 204 M | 200 M | 162 M | 134 M | ||
Shsout | 127 M | 132 M | 131 M | 129 M | 128 M | 105 M | 92 M | 39 M | 39 M | |
Specincchg | -4 M | -2 M | -5 M | 2 M | 423000.0 | |||||
Taxprov | -4 M | 5 M | 5 M | -31 M | 530000.0 | 150000.0 | 84000.0 | -7 M |